Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 14Carcinoma, Non-Small-Cell Lung 13Neoplasms 10Glioblastoma 9Fallopian Tube Neoplasms 8Colorectal Neoplasms 8Breast Neoplasms 8Lung Neoplasms 7Rectal Neoplasms 6Neoplasm Metastasis 6Gliosarcoma 6Colonic Neoplasms 6Carcinoma, Renal Cell 6Brain Neoplasms 6Prostatic Neoplasms 4Melanoma 4Uterine Cervical Neoplasms 3Solitary Fibrous Tumor, Pleural 3Sarcoma, Alveolar Soft Part 3Sarcoma 3Mesothelioma, Malignant 3Carcinoma, Hepatocellular 3Breast Neoplasms, Male 3Advanced Solid Tumor 3Uveal Melanoma 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Leukemia, Myeloid, Acute 2

Interventions

AZD 6244 10trametinib 4pirfenidone 3dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurofibroma, Plexiform × cediranib × Clear all
NCT00326872 2017-08-18

AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

National Cancer Institute (NCI)

Phase 2 Terminated
26 enrolled 8 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡